data_1krs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1krs _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.763 ' CE1' ' CE1' ' A' ' 44' ' ' HIS . 1.9 t80 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.614 ' N ' ' HB3' ' A' ' 44' ' ' HIS . 63.7 mtt85 -107.83 -158.72 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.293 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.503 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -79.89 116.55 20.11 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-O 123.973 1.844 . . . . 0.0 115.4 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 61.37 44.4 9.61 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 88.318 -8.401 . . . . 0.0 88.318 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.789 ' CD2' ' CB ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -13.94 -100.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 46' ' ' SER . 3.1 p -125.34 -176.65 3.64 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 110.761 -2.927 . . . . 0.0 109.771 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.583 ' HB3' ' CB ' ' A' ' 49' ' ' LEU . 15.8 m 98.06 89.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 129.047 3.967 . . . . 0.0 115.607 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -102.19 -49.68 3.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -37.33 7.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 125.272 2.463 . . . . 0.0 106.27 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.647 HD13 ' CD2' ' A' ' 128' ' ' LEU 0.261 0.3 OUTLIER -47.03 -67.34 0.29 Allowed 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 109.259 -3.609 . . . . 0.0 112.775 179.929 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' CD2' HD11 ' A' ' 49' ' ' LEU . 11.1 m170 -48.79 -38.62 22.51 Favored 'General case' 0 C--N 1.275 -2.662 1 CA-C-N 107.51 -4.404 . . . . 0.0 110.321 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.35 -41.38 93.53 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 117.834 -1.546 . . . . 0.0 107.762 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.9 tp10 -76.1 -63.63 1.27 Allowed 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 112.826 -1.988 . . . . 0.0 115.65 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.773 ' CE2' ' HG ' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -38.44 -37.21 0.29 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 127.139 2.176 . . . . 0.0 109.903 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.52 73.1 3.24 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 110.107 -3.224 . . . . 0.0 111.58 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.05 -1.64 3.13 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -121.22 -167.97 1.59 Allowed 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 121.731 2.765 . . . . 0.0 114.544 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.94 152.69 23.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -49.59 -63.86 0.98 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 124.577 2.132 . . . . 0.0 116.542 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -32.42 -48.6 0.18 Allowed 'General case' 0 C--N 1.292 -1.934 1 CA-C-N 108.139 -4.119 . . . . 0.0 111.509 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.445 ' O ' HD22 ' A' ' 64' ' ' LEU . 2.9 tt0 -69.69 -59.81 2.72 Favored 'General case' 0 C--N 1.283 -2.32 2 CA-C-N 102.247 -6.797 . . . . 0.0 110.879 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.75 HD11 ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -44.83 -28.5 0.65 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 124.78 2.228 . . . . 0.0 114.248 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 65' ' ' ASN 0.258 29.2 mt-10 -79.61 -47.3 15.68 Favored 'General case' 0 C--N 1.278 -2.537 1 CA-C-N 107.839 -4.255 . . . . 0.0 114.365 -179.02 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.37 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 110.702 -2.954 . . . . 0.0 104.616 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.445 HD22 ' O ' ' A' ' 60' ' ' GLU . 2.2 pp -85.48 -25.09 27.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 121.116 3.747 . . . . 0.0 121.116 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 3.0 p-10 -15.51 143.37 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.75 2 CA-C-N 106.495 -4.866 . . . . 0.0 119.334 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.287 5.5 tp -119.96 141.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 1 CA-C-N 106.454 -4.885 . . . . 0.0 105.049 -179.656 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.58 ' O ' ' CE1' ' A' ' 44' ' ' HIS . 28.7 mt-10 -111.0 66.28 0.62 Allowed 'General case' 0 C--N 1.285 -2.201 1 CA-C-N 107.397 -4.456 . . . . 0.0 108.212 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.683 ' HA ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.85 148.73 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.676 1 CA-C-O 130.591 4.996 . . . . 0.0 113.579 -179.07 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' CB ' ' CD2' ' A' ' 44' ' ' HIS 0.321 . . -88.65 -178.19 5.74 Favored 'General case' 0 CA--C 1.43 -3.642 4 CA-C-N 98.144 -8.662 . . . . 0.0 132.37 -177.524 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.485 HG12 ' C ' ' A' ' 69' ' ' ALA . 17.0 m -149.03 114.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 2 CA-C-N 98.69 -8.413 . . . . 0.0 110.216 178.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.503 ' H ' ' HB3' ' A' ' 42' ' ' ARG . . . -122.71 176.92 5.69 Favored 'General case' 0 C--N 1.26 -3.289 2 CA-C-N 106.421 -4.9 . . . . 0.0 99.72 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.477 ' O ' HD11 ' A' ' 122' ' ' LEU . . . 92.86 -142.37 15.95 Favored Glycine 0 N--CA 1.504 3.198 1 C-N-CA 113.859 -4.02 . . . . 0.0 109.582 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.68 148.28 12.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.749 ' CB ' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -161.81 -149.62 0.17 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 74' ' ' MET . 15.3 ptp 179.19 9.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.015 -2.357 . . . . 0.0 113.747 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.24 97.52 9.23 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.412 ' CB ' HD22 ' A' ' 110' ' ' ASN . 0.0 OUTLIER -101.04 170.97 7.92 Favored 'General case' 0 C--N 1.291 -1.956 1 CA-C-N 106.925 -4.671 . . . . 0.0 115.863 -179.568 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 51.96 1.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -47.6 153.85 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 120.691 3.589 . . . . 0.0 120.691 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 21.7 ptm -152.09 38.73 0.58 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 109.35 -3.568 . . . . 0.0 106.728 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.02 -70.17 0.57 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -119.95 -151.03 0.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 115.253 -2.308 . . . . 0.0 105.526 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' CA ' ' HE2' ' A' ' 109' ' ' TYR . . . -3.21 114.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 124.452 2.072 . . . . 0.0 115.539 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.6 m -122.96 178.69 4.95 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.083 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -121.1 132.66 55.0 Favored 'General case' 0 C--N 1.297 -1.696 1 N-CA-C 96.477 -5.379 . . . . 0.0 96.477 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.549 HG13 ' CE2' ' A' ' 113' ' ' PHE . 4.3 t -126.49 170.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.501 ' N ' ' CG1' ' A' ' 86' ' ' VAL . 92.8 m -146.02 127.9 15.41 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.749 ' HA ' ' CB ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -122.12 168.21 12.24 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 126.376 2.298 . . . . 0.0 116.267 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.476 ' HA ' ' HG3' ' A' ' 94' ' ' ARG . 80.1 mt-30 -119.0 159.26 24.18 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.97 1.419 . . . . 0.0 107.933 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.85 -174.21 3.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.422 HG13 ' N ' ' A' ' 92' ' ' GLY . 2.5 t -24.48 -60.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 125.962 2.039 . . . . 0.0 115.549 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.422 ' N ' HG13 ' A' ' 91' ' ' VAL . . . -138.46 33.64 2.2 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.123 -1.513 . . . . 0.0 114.014 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.79 174.33 42.26 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 115.711 -3.138 . . . . 0.0 111.41 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HG3' ' HA ' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -120.61 164.19 16.87 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 123.931 1.824 . . . . 0.0 115.401 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.37 157.61 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 CA-C-N 109.315 -3.584 . . . . 0.0 107.7 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.01 146.59 44.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.536 HD22 ' N ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -132.61 -177.89 4.69 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 124.146 1.927 . . . . 0.0 113.551 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.651 ' CE1' ' HB3' ' A' ' 100' ' ' ALA 0.264 1.8 t80 -130.39 103.35 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.987 -3.733 . . . . 0.0 109.753 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG13 ' CD2' ' A' ' 109' ' ' TYR . 70.2 t -89.04 90.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.651 ' HB3' ' CE1' ' A' ' 98' ' ' TYR . . . -123.11 118.78 28.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 116.923 -1.911 . . . . 0.0 113.82 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.1 49.42 0.91 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -42.54 -32.54 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.585 -2.098 . . . . 0.0 114.515 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -101.49 -54.78 2.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.45 86.75 8.6 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.99 64.06 1.93 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 124.756 3.637 . . . . 0.0 115.518 -162.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.75 179.24 0.18 Allowed 'General case' 0 C--N 1.3 -1.571 1 N-CA-C 124.519 5.007 . . . . 0.0 124.519 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.591 ' C ' ' H ' ' A' ' 109' ' ' TYR . . . -116.36 -25.03 3.61 Favored Glycine 0 N--CA 1.501 2.977 0 CA-C-N 108.653 -3.885 . . . . 0.0 106.159 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.09 -19.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 126.325 2.964 . . . . 0.0 108.148 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.643 ' CG ' ' N ' ' A' ' 110' ' ' ASN 0.322 0.0 OUTLIER -74.68 -144.19 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 1 CA-C-N 107.368 -4.469 . . . . 0.0 114.741 178.91 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.643 ' N ' ' CG ' ' A' ' 109' ' ' TYR . 64.0 t30 -40.43 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.6 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 114' ' ' LYS . 3.6 tt0 -88.91 -37.35 15.35 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 117.168 -1.813 . . . . 0.0 112.952 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.601 ' O ' ' NE1' ' A' ' 116' ' ' TRP 0.499 32.0 tt0 -59.6 -55.22 37.21 Favored 'General case' 0 C--N 1.282 -2.342 1 N-CA-C 93.078 -6.638 . . . . 0.0 93.078 178.904 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.619 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 1.3 m-30 -47.72 -35.33 9.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.87 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.468 ' H ' ' C ' ' A' ' 111' ' ' GLU . 81.4 tttt -62.57 -34.39 76.87 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.641 -2.072 . . . . 0.0 107.561 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 112' ' ' GLN . 3.1 tttm -73.39 -32.54 64.51 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.388 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TRP . . . . . 0.661 ' CZ2' ' HG ' ' A' ' 145' ' ' LEU . 26.8 m95 -74.09 134.68 42.93 Favored 'General case' 0 N--CA 1.487 1.401 2 N-CA-C 123.052 4.464 . . . . 0.0 123.052 -178.797 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -108.86 -173.5 2.28 Favored 'General case' 0 C--N 1.291 -1.948 2 CA-C-N 103.69 -6.141 . . . . 0.0 121.588 -179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.548 ' H ' ' CD1' ' A' ' 118' ' ' LEU . 0.5 OUTLIER -28.98 -114.63 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 2 CA-C-N 103.389 -6.278 . . . . 0.0 119.953 179.827 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.9 -49.41 66.81 Favored Glycine 0 N--CA 1.495 2.627 0 CA-C-N 110.515 -3.039 . . . . 0.0 108.971 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . 0.325 12.0 t0 -47.27 143.68 3.2 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 111.131 -2.535 . . . . 0.0 104.819 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.622 ' N ' ' CD1' ' A' ' 146' ' ' LEU . 5.0 mt -127.55 166.96 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 1 N-CA-C 122.789 4.366 . . . . 0.0 122.789 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.639 HD11 ' N ' ' A' ' 122' ' ' LEU . 1.2 mp -108.07 165.21 11.65 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 117.044 -3.535 . . . . 0.0 106.931 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.5 108.6 0.47 Allowed Glycine 0 N--CA 1.489 2.178 2 N-CA-C 92.776 -8.13 . . . . 0.0 92.776 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.611 ' O ' ' CB ' ' A' ' 69' ' ' ALA . . . -140.03 -178.29 5.39 Favored 'General case' 0 CA--C 1.439 -3.32 0 CA-C-N 124.047 3.923 . . . . 0.0 104.44 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.507 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -152.43 150.03 29.22 Favored 'General case' 0 C--N 1.289 -2.055 0 O-C-N 126.709 2.506 . . . . 0.0 114.92 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 68' ' ' VAL . . . -158.72 154.69 25.77 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 105.76 -2.936 . . . . 0.0 105.76 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 22.8 pttt -86.65 170.69 11.59 Favored 'General case' 0 CA--C 1.462 -2.435 1 C-N-CA 111.212 -4.195 . . . . 0.0 110.475 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.773 ' HG ' ' CE2' ' A' ' 53' ' ' PHE 0.257 0.1 OUTLIER -91.07 134.1 34.78 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 114.216 -2.994 . . . . 0.0 106.469 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.568 ' CD1' ' HB2' ' A' ' 139' ' ' HIS . 12.5 p90 -154.92 161.72 41.33 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 115.937 -2.305 . . . . 0.0 114.919 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -46.48 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 2 CA-C-N 106.285 -4.961 . . . . 0.0 115.193 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.429 ' OG1' ' HB3' ' A' ' 137' ' ' SER . 13.8 m -94.37 -58.45 2.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.598 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.82 -45.4 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 125.77 1.918 . . . . 0.0 113.245 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.5 t -106.5 -25.37 11.87 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.542 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.37 2.68 4.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.419 ' O ' ' O ' ' A' ' 129' ' ' PHE . 21.8 tt0 -112.5 -112.42 0.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.535 ' CD1' ' C ' ' A' ' 136' ' ' LEU 0.257 0.3 OUTLIER -21.12 7.29 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.278 2 N-CA-C 137.413 9.783 . . . . 0.0 137.413 -178.918 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.482 ' N ' HD13 ' A' ' 136' ' ' LEU . 18.3 t -115.98 160.49 20.18 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 112.178 -3.809 . . . . 0.0 106.684 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.412 ' N ' ' OG ' ' A' ' 137' ' ' SER . 15.5 mt -96.85 145.79 8.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 117.371 -1.732 . . . . 0.0 110.33 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 17.8 t-160 -117.03 77.95 1.17 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 111.32 -2.673 . . . . 0.0 106.809 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.42 121.5 9.11 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 109.39 -3.55 . . . . 0.0 115.74 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.8 p -132.83 -31.66 1.3 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 110.375 -3.102 . . . . 0.0 113.844 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.14 128.81 48.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.431 HD21 ' CE1' ' A' ' 113' ' ' PHE . 5.6 mp -116.27 114.07 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.62 91.15 3.55 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 124.299 1.999 . . . . 0.0 110.88 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.661 ' HG ' ' CZ2' ' A' ' 116' ' ' TRP 0.269 4.5 mm? -77.05 161.1 28.57 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 111.358 -2.656 . . . . 0.0 111.204 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.666 ' N ' ' CD2' ' A' ' 146' ' ' LEU 0.279 1.1 pt? -78.61 -168.82 1.5 Allowed 'General case' 0 N--CA 1.425 -1.716 2 CA-C-O 133.124 6.202 . . . . 0.0 121.196 -179.492 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 15.0 t -118.98 175.53 5.72 Favored 'General case' 0 C--N 1.272 -2.803 3 CA-C-N 91.266 -11.788 . . . . 0.0 102.195 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 142.35 27.44 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.862 -2.881 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 115.391 -2.242 . . . . 0.0 108.89 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.763 ' CE1' ' CE1' ' A' ' 44' ' ' HIS . 1.9 t80 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 63.7 mtt85 -107.83 -158.72 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.293 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.688 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -79.89 116.55 20.11 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-O 123.973 1.844 . . . . 0.0 115.4 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 61.37 44.4 9.61 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 88.318 -8.401 . . . . 0.0 88.318 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.789 ' CD2' ' CB ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -13.94 -100.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 44' ' ' HIS . 3.1 p -125.34 -176.65 3.64 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 110.761 -2.927 . . . . 0.0 109.771 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.644 ' HB3' ' CB ' ' A' ' 49' ' ' LEU . 15.8 m 98.06 89.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 129.047 3.967 . . . . 0.0 115.607 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -102.19 -49.68 3.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -46.3 -37.33 7.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 125.272 2.463 . . . . 0.0 106.27 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 128' ' ' LEU 0.261 0.3 OUTLIER -47.03 -67.34 0.29 Allowed 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 109.259 -3.609 . . . . 0.0 112.775 179.929 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.405 ' ND1' HD12 ' A' ' 49' ' ' LEU . 1.4 m80 -48.79 -38.62 22.51 Favored 'General case' 0 C--N 1.275 -2.662 1 CA-C-N 107.51 -4.404 . . . . 0.0 110.321 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' GLN . . . -60.35 -41.38 93.53 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 117.834 -1.546 . . . . 0.0 107.762 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.9 tp10 -76.1 -63.63 1.27 Allowed 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 112.826 -1.988 . . . . 0.0 115.65 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.96 ' CE1' HD12 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -38.44 -37.21 0.29 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 127.139 2.176 . . . . 0.0 109.903 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.52 73.1 3.24 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 110.107 -3.224 . . . . 0.0 111.58 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.05 -1.64 3.13 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 61' ' ' LEU . 14.5 ptpt -121.22 -167.97 1.59 Allowed 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 121.731 2.765 . . . . 0.0 114.544 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.94 152.69 23.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -49.59 -63.86 0.98 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 124.577 2.132 . . . . 0.0 116.542 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 24.9 tt0 -32.42 -48.6 0.18 Allowed 'General case' 0 C--N 1.292 -1.934 1 CA-C-N 108.139 -4.119 . . . . 0.0 111.509 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.69 -59.81 2.72 Favored 'General case' 0 C--N 1.283 -2.32 2 CA-C-N 102.247 -6.797 . . . . 0.0 110.879 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.96 HD12 ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -44.83 -28.5 0.65 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 124.78 2.228 . . . . 0.0 114.248 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 65' ' ' ASN 0.258 29.2 mt-10 -79.61 -47.3 15.68 Favored 'General case' 0 C--N 1.278 -2.537 1 CA-C-N 107.839 -4.255 . . . . 0.0 114.365 -179.02 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.37 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 110.702 -2.954 . . . . 0.0 104.616 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 61' ' ' LEU . 2.2 pp -85.48 -25.09 27.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 121.116 3.747 . . . . 0.0 121.116 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 3.0 p-10 -15.51 143.37 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.75 2 CA-C-N 106.495 -4.866 . . . . 0.0 119.334 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.287 5.5 tp -119.96 141.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 1 CA-C-N 106.454 -4.885 . . . . 0.0 105.049 -179.656 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 28.7 mt-10 -111.0 66.28 0.62 Allowed 'General case' 0 C--N 1.285 -2.201 1 CA-C-N 107.397 -4.456 . . . . 0.0 108.212 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.75 ' HA ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.85 148.73 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.676 1 CA-C-O 130.591 4.996 . . . . 0.0 113.579 -179.07 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' CB ' ' CD2' ' A' ' 44' ' ' HIS 0.321 . . -88.65 -178.19 5.74 Favored 'General case' 0 CA--C 1.43 -3.642 4 CA-C-N 98.144 -8.662 . . . . 0.0 132.37 -177.524 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.678 ' CG2' ' HB3' ' A' ' 124' ' ' ALA . 17.0 m -149.03 114.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 2 CA-C-N 98.69 -8.413 . . . . 0.0 110.216 178.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.688 ' H ' ' HB3' ' A' ' 42' ' ' ARG . . . -122.71 176.92 5.69 Favored 'General case' 0 C--N 1.26 -3.289 2 CA-C-N 106.421 -4.9 . . . . 0.0 99.72 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 122' ' ' LEU . . . 92.86 -142.37 15.95 Favored Glycine 0 N--CA 1.504 3.198 1 C-N-CA 113.859 -4.02 . . . . 0.0 109.582 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -162.68 148.28 12.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.731 ' CB ' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -161.81 -149.62 0.17 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 74' ' ' MET . 15.3 ptp 179.19 9.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.015 -2.357 . . . . 0.0 113.747 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.24 97.52 9.23 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -101.04 170.97 7.92 Favored 'General case' 0 C--N 1.291 -1.956 1 CA-C-N 106.925 -4.671 . . . . 0.0 115.863 -179.568 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 51.96 1.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -47.6 153.85 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 120.691 3.589 . . . . 0.0 120.691 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 21.7 ptm -152.09 38.73 0.58 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 109.35 -3.568 . . . . 0.0 106.728 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.02 -70.17 0.57 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -119.95 -151.03 0.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 115.253 -2.308 . . . . 0.0 105.526 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.491 ' HA ' ' HE2' ' A' ' 109' ' ' TYR . . . -3.21 114.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 124.452 2.072 . . . . 0.0 115.539 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.6 m -122.96 178.69 4.95 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.083 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -121.1 132.66 55.0 Favored 'General case' 0 C--N 1.297 -1.696 1 N-CA-C 96.477 -5.379 . . . . 0.0 96.477 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 113' ' ' PHE . 4.3 t -126.49 170.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.501 ' N ' ' CG1' ' A' ' 86' ' ' VAL . 92.8 m -146.02 127.9 15.41 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.731 ' HA ' ' CB ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -122.12 168.21 12.24 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 126.376 2.298 . . . . 0.0 116.267 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HG2' ' HG3' ' A' ' 94' ' ' ARG . 80.1 mt-30 -119.0 159.26 24.18 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.97 1.419 . . . . 0.0 107.933 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.85 -174.21 3.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 92' ' ' GLY . 2.5 t -24.48 -60.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 125.962 2.039 . . . . 0.0 115.549 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 91' ' ' VAL . . . -138.46 33.64 2.2 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.123 -1.513 . . . . 0.0 114.014 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.79 174.33 42.26 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 115.711 -3.138 . . . . 0.0 111.41 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.546 ' HG3' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -120.61 164.19 16.87 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 123.931 1.824 . . . . 0.0 115.401 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.37 157.61 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 CA-C-N 109.315 -3.584 . . . . 0.0 107.7 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.01 146.59 44.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -132.61 -177.89 4.69 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 124.146 1.927 . . . . 0.0 113.551 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.698 ' CE1' ' HB2' ' A' ' 100' ' ' ALA 0.264 1.8 t80 -130.39 103.35 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.987 -3.733 . . . . 0.0 109.753 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 109' ' ' TYR . 70.2 t -89.04 90.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.698 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -123.11 118.78 28.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 116.923 -1.911 . . . . 0.0 113.82 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -112.1 49.42 0.91 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -42.54 -32.54 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.585 -2.098 . . . . 0.0 114.515 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -101.49 -54.78 2.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.45 86.75 8.6 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 101' ' ' ARG . 41.6 Cg_endo -69.99 64.06 1.93 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 124.756 3.637 . . . . 0.0 115.518 -162.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.75 179.24 0.18 Allowed 'General case' 0 C--N 1.3 -1.571 1 N-CA-C 124.519 5.007 . . . . 0.0 124.519 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 109' ' ' TYR . . . -116.36 -25.03 3.61 Favored Glycine 0 N--CA 1.501 2.977 0 CA-C-N 108.653 -3.885 . . . . 0.0 106.159 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.09 -19.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 126.325 2.964 . . . . 0.0 108.148 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.707 ' CE1' ' HB3' ' A' ' 110' ' ' ASN 0.322 0.0 OUTLIER -74.68 -144.19 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 1 CA-C-N 107.368 -4.469 . . . . 0.0 114.741 178.91 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.707 ' HB3' ' CE1' ' A' ' 109' ' ' TYR . 64.0 t30 -40.43 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.6 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 114' ' ' LYS . 3.6 tt0 -88.91 -37.35 15.35 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 117.168 -1.813 . . . . 0.0 112.952 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.601 ' O ' ' NE1' ' A' ' 116' ' ' TRP 0.499 32.0 tt0 -59.6 -55.22 37.21 Favored 'General case' 0 C--N 1.282 -2.342 1 N-CA-C 93.078 -6.638 . . . . 0.0 93.078 178.904 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.679 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 1.3 m-30 -47.72 -35.33 9.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.87 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 111' ' ' GLU . 81.4 tttt -62.57 -34.39 76.87 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.641 -2.072 . . . . 0.0 107.561 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 112' ' ' GLN . 3.1 tttm -73.39 -32.54 64.51 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.388 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TRP . . . . . 0.679 ' CD1' ' HA ' ' A' ' 113' ' ' PHE . 26.8 m95 -74.09 134.68 42.93 Favored 'General case' 0 N--CA 1.487 1.401 2 N-CA-C 123.052 4.464 . . . . 0.0 123.052 -178.797 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 118' ' ' LEU . 11.1 p-10 -108.86 -173.5 2.28 Favored 'General case' 0 C--N 1.291 -1.948 2 CA-C-N 103.69 -6.141 . . . . 0.0 121.588 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.664 ' H ' HD13 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -28.98 -114.63 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 2 CA-C-N 103.389 -6.278 . . . . 0.0 119.953 179.827 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.9 -49.41 66.81 Favored Glycine 0 N--CA 1.495 2.627 0 CA-C-N 110.515 -3.039 . . . . 0.0 108.971 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 146' ' ' LEU 0.325 12.0 t0 -47.27 143.68 3.2 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 111.131 -2.535 . . . . 0.0 104.819 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.957 ' O ' ' HB3' ' A' ' 146' ' ' LEU . 5.0 mt -127.55 166.96 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 1 N-CA-C 122.789 4.366 . . . . 0.0 122.789 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.636 ' C ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mp -108.07 165.21 11.65 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 117.044 -3.535 . . . . 0.0 106.931 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.5 108.6 0.47 Allowed Glycine 0 N--CA 1.489 2.178 2 N-CA-C 92.776 -8.13 . . . . 0.0 92.776 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.678 ' HB3' ' CG2' ' A' ' 70' ' ' VAL . . . -140.03 -178.29 5.39 Favored 'General case' 0 CA--C 1.439 -3.32 0 CA-C-N 124.047 3.923 . . . . 0.0 104.44 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -152.43 150.03 29.22 Favored 'General case' 0 C--N 1.289 -2.055 0 O-C-N 126.709 2.506 . . . . 0.0 114.92 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 68' ' ' VAL . . . -158.72 154.69 25.77 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 105.76 -2.936 . . . . 0.0 105.76 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 22.8 pttt -86.65 170.69 11.59 Favored 'General case' 0 CA--C 1.462 -2.435 1 C-N-CA 111.212 -4.195 . . . . 0.0 110.475 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.737 HD21 ' CG ' ' A' ' 53' ' ' PHE 0.257 0.1 OUTLIER -91.07 134.1 34.78 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 114.216 -2.994 . . . . 0.0 106.469 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 139' ' ' HIS . 12.5 p90 -154.92 161.72 41.33 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 115.937 -2.305 . . . . 0.0 114.919 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -46.48 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 2 CA-C-N 106.285 -4.961 . . . . 0.0 115.193 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 137' ' ' SER . 13.8 m -94.37 -58.45 2.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.598 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.82 -45.4 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 125.77 1.918 . . . . 0.0 113.245 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.5 t -106.5 -25.37 11.87 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.542 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.37 2.68 4.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 128' ' ' LEU . 21.8 tt0 -112.5 -112.42 0.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 136' ' ' LEU 0.257 0.3 OUTLIER -21.12 7.29 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.278 2 N-CA-C 137.413 9.783 . . . . 0.0 137.413 -178.918 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.573 ' N ' HD12 ' A' ' 136' ' ' LEU . 18.3 t -115.98 160.49 20.18 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 112.178 -3.809 . . . . 0.0 106.684 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.475 HG23 ' HA3' ' A' ' 126' ' ' GLY . 15.5 mt -96.85 145.79 8.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 117.371 -1.732 . . . . 0.0 110.33 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 17.8 t-160 -117.03 77.95 1.17 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 111.32 -2.673 . . . . 0.0 106.809 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.42 121.5 9.11 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 109.39 -3.55 . . . . 0.0 115.74 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.8 p -132.83 -31.66 1.3 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 110.375 -3.102 . . . . 0.0 113.844 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.14 128.81 48.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.465 HD23 ' CE1' ' A' ' 113' ' ' PHE . 5.6 mp -116.27 114.07 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -112.62 91.15 3.55 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 124.299 1.999 . . . . 0.0 110.88 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.629 ' HG ' ' CZ2' ' A' ' 116' ' ' TRP 0.269 4.5 mm? -77.05 161.1 28.57 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 111.358 -2.656 . . . . 0.0 111.204 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.957 ' HB3' ' O ' ' A' ' 121' ' ' ILE 0.279 1.1 pt? -78.61 -168.82 1.5 Allowed 'General case' 0 N--CA 1.425 -1.716 2 CA-C-O 133.124 6.202 . . . . 0.0 121.196 -179.492 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 15.0 t -118.98 175.53 5.72 Favored 'General case' 0 C--N 1.272 -2.803 3 CA-C-N 91.266 -11.788 . . . . 0.0 102.195 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 142.35 27.44 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.862 -2.881 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 115.391 -2.242 . . . . 0.0 108.89 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.763 ' CE1' ' CE1' ' A' ' 44' ' ' HIS . 1.9 t80 . . . . . 0 CA--C 1.552 1.051 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.628 ' O ' ' HB3' ' A' ' 69' ' ' ALA . 63.7 mtt85 -107.83 -158.72 0.66 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 111.63 -2.532 . . . . 0.0 112.293 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.688 ' HB3' ' H ' ' A' ' 71' ' ' ALA . 0.5 OUTLIER -79.89 116.55 20.11 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-O 123.973 1.844 . . . . 0.0 115.4 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t70 61.37 44.4 9.61 Favored 'General case' 0 N--CA 1.491 1.607 1 N-CA-C 88.318 -8.401 . . . . 0.0 88.318 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.789 ' CD2' ' CB ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -13.94 -100.17 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 120.445 3.498 . . . . 0.0 120.445 -178.138 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.472 ' H ' ' HB2' ' A' ' 44' ' ' HIS . 3.1 p -125.34 -176.65 3.64 Favored 'General case' 0 C--N 1.264 -3.133 0 CA-C-N 110.761 -2.927 . . . . 0.0 109.771 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.644 ' HB3' ' CB ' ' A' ' 49' ' ' LEU . 15.8 m 98.06 89.75 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 O-C-N 129.047 3.967 . . . . 0.0 115.607 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -102.19 -49.68 3.84 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 103.987 -2.598 . . . . 0.0 103.987 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 51' ' ' ALA . 0.0 OUTLIER -46.3 -37.33 7.21 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-O 125.272 2.463 . . . . 0.0 106.27 179.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.682 HD11 ' CD2' ' A' ' 128' ' ' LEU 0.261 0.3 OUTLIER -47.03 -67.34 0.29 Allowed 'General case' 0 N--CA 1.414 -2.235 0 CA-C-N 109.259 -3.609 . . . . 0.0 112.775 179.929 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.601 ' CD2' HD12 ' A' ' 49' ' ' LEU . 11.1 m170 -48.79 -38.62 22.51 Favored 'General case' 0 C--N 1.275 -2.662 1 CA-C-N 107.51 -4.404 . . . . 0.0 110.321 -178.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 48' ' ' GLN . . . -60.35 -41.38 93.53 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 117.834 -1.546 . . . . 0.0 107.762 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.9 tp10 -76.1 -63.63 1.27 Allowed 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 112.826 -1.988 . . . . 0.0 115.65 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.96 ' CE1' HD12 ' A' ' 61' ' ' LEU . 0.2 OUTLIER -38.44 -37.21 0.29 Allowed 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 127.139 2.176 . . . . 0.0 109.903 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -76.52 73.1 3.24 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 110.107 -3.224 . . . . 0.0 111.58 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.05 -1.64 3.13 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.424 ' HG3' ' CD2' ' A' ' 61' ' ' LEU . 14.5 ptpt -121.22 -167.97 1.59 Allowed 'General case' 0 N--CA 1.507 2.398 0 CA-C-N 121.731 2.765 . . . . 0.0 114.544 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -84.94 152.69 23.33 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 117.65 2.463 . . . . 0.0 117.65 -179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.3 m-80 -49.59 -63.86 0.98 Allowed 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 124.577 2.132 . . . . 0.0 116.542 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 24.9 tt0 -32.42 -48.6 0.18 Allowed 'General case' 0 C--N 1.292 -1.934 1 CA-C-N 108.139 -4.119 . . . . 0.0 111.509 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -69.69 -59.81 2.72 Favored 'General case' 0 C--N 1.283 -2.32 2 CA-C-N 102.247 -6.797 . . . . 0.0 110.879 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.96 HD12 ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -44.83 -28.5 0.65 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 124.78 2.228 . . . . 0.0 114.248 -179.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.616 ' HA ' ' HB3' ' A' ' 65' ' ' ASN 0.258 29.2 mt-10 -79.61 -47.3 15.68 Favored 'General case' 0 C--N 1.278 -2.537 1 CA-C-N 107.839 -4.255 . . . . 0.0 114.365 -179.02 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.37 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 110.702 -2.954 . . . . 0.0 104.616 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' A' ' 61' ' ' LEU . 2.2 pp -85.48 -25.09 27.09 Favored 'General case' 0 CA--C 1.488 -1.439 0 N-CA-C 121.116 3.747 . . . . 0.0 121.116 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 3.0 p-10 -15.51 143.37 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.75 2 CA-C-N 106.495 -4.866 . . . . 0.0 119.334 -178.409 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . 0.287 5.5 tp -119.96 141.15 41.46 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.095 1 CA-C-N 106.454 -4.885 . . . . 0.0 105.049 -179.656 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 127' ' ' LYS . 28.7 mt-10 -111.0 66.28 0.62 Allowed 'General case' 0 C--N 1.285 -2.201 1 CA-C-N 107.397 -4.456 . . . . 0.0 108.212 -179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.75 ' HA ' ' CE1' ' A' ' 44' ' ' HIS . 0.0 OUTLIER -78.85 148.73 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.455 -2.676 1 CA-C-O 130.591 4.996 . . . . 0.0 113.579 -179.07 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.789 ' CB ' ' CD2' ' A' ' 44' ' ' HIS 0.321 . . -88.65 -178.19 5.74 Favored 'General case' 0 CA--C 1.43 -3.642 4 CA-C-N 98.144 -8.662 . . . . 0.0 132.37 -177.524 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.678 ' CG2' ' HB3' ' A' ' 124' ' ' ALA . 17.0 m -149.03 114.21 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.811 2 CA-C-N 98.69 -8.413 . . . . 0.0 110.216 178.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.688 ' H ' ' HB3' ' A' ' 42' ' ' ARG . . . -122.71 176.92 5.69 Favored 'General case' 0 C--N 1.26 -3.289 2 CA-C-N 106.421 -4.9 . . . . 0.0 99.72 179.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' HD13 ' A' ' 122' ' ' LEU . . . 92.86 -142.37 15.95 Favored Glycine 0 N--CA 1.504 3.198 1 C-N-CA 113.859 -4.02 . . . . 0.0 109.582 179.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.402 ' HD2' ' HA ' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -162.68 148.28 12.32 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 116.919 2.192 . . . . 0.0 116.919 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.731 ' CB ' ' HA ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -161.81 -149.62 0.17 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 179.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.56 ' N ' ' SD ' ' A' ' 74' ' ' MET . 15.3 ptp 179.19 9.9 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 112.015 -2.357 . . . . 0.0 113.747 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.24 97.52 9.23 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 121.124 3.75 . . . . 0.0 121.124 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.466 ' C ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -101.04 170.97 7.92 Favored 'General case' 0 C--N 1.291 -1.956 1 CA-C-N 106.925 -4.671 . . . . 0.0 115.863 -179.568 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 51.96 1.6 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.6 pp -47.6 153.85 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 120.691 3.589 . . . . 0.0 120.691 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 21.7 ptm -152.09 38.73 0.58 Allowed 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 109.35 -3.568 . . . . 0.0 106.728 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 99.02 -70.17 0.57 Allowed Glycine 0 N--CA 1.492 2.379 0 CA-C-N 111.361 -2.654 . . . . 0.0 109.586 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' O ' ' C ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -119.95 -151.03 0.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 CA-C-O 115.253 -2.308 . . . . 0.0 105.526 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.491 ' HA ' ' HE2' ' A' ' 109' ' ' TYR . . . -3.21 114.12 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 124.452 2.072 . . . . 0.0 115.539 -179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 63.6 m -122.96 178.69 4.95 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-N 109.124 -3.671 . . . . 0.0 114.083 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -121.1 132.66 55.0 Favored 'General case' 0 C--N 1.297 -1.696 1 N-CA-C 96.477 -5.379 . . . . 0.0 96.477 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 113' ' ' PHE . 4.3 t -126.49 170.22 16.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.501 ' N ' ' CG1' ' A' ' 86' ' ' VAL . 92.8 m -146.02 127.9 15.41 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.731 ' HA ' ' CB ' ' A' ' 74' ' ' MET . 0.3 OUTLIER -122.12 168.21 12.24 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 126.376 2.298 . . . . 0.0 116.267 -179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.546 ' HG2' ' HG3' ' A' ' 94' ' ' ARG . 80.1 mt-30 -119.0 159.26 24.18 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.97 1.419 . . . . 0.0 107.933 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -137.85 -174.21 3.72 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 102.906 -2.998 . . . . 0.0 102.906 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 92' ' ' GLY . 2.5 t -24.48 -60.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 O-C-N 125.962 2.039 . . . . 0.0 115.549 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 91' ' ' VAL . . . -138.46 33.64 2.2 Favored Glycine 0 N--CA 1.488 2.161 0 C-N-CA 119.123 -1.513 . . . . 0.0 114.014 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 175.79 174.33 42.26 Favored Glycine 0 N--CA 1.496 2.685 0 C-N-CA 115.711 -3.138 . . . . 0.0 111.41 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.546 ' HG3' ' HG2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -120.61 164.19 16.87 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-O 123.931 1.824 . . . . 0.0 115.401 179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.37 157.61 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 CA-C-N 109.315 -3.584 . . . . 0.0 107.7 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -119.01 146.59 44.9 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.588 HD23 ' N ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -132.61 -177.89 4.69 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 124.146 1.927 . . . . 0.0 113.551 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.698 ' CE1' ' HB2' ' A' ' 100' ' ' ALA 0.264 1.8 t80 -130.39 103.35 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 108.987 -3.733 . . . . 0.0 109.753 -179.192 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.521 HG12 ' CD2' ' A' ' 109' ' ' TYR . 70.2 t -89.04 90.87 3.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.698 ' HB2' ' CE1' ' A' ' 98' ' ' TYR . . . -123.11 118.78 28.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 116.923 -1.911 . . . . 0.0 113.82 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER -112.1 49.42 0.91 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -42.54 -32.54 0.57 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.585 -2.098 . . . . 0.0 114.515 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -101.49 -54.78 2.68 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.45 86.75 8.6 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.496 ' HA ' ' HB2' ' A' ' 101' ' ' ARG . 41.6 Cg_endo -69.99 64.06 1.93 Allowed 'Trans proline' 0 N--CA 1.497 1.69 0 C-N-CA 124.756 3.637 . . . . 0.0 115.518 -162.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -60.75 179.24 0.18 Allowed 'General case' 0 C--N 1.3 -1.571 1 N-CA-C 124.519 5.007 . . . . 0.0 124.519 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.615 ' C ' ' H ' ' A' ' 109' ' ' TYR . . . -116.36 -25.03 3.61 Favored Glycine 0 N--CA 1.501 2.977 0 CA-C-N 108.653 -3.885 . . . . 0.0 106.159 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 72.2 t -47.09 -19.51 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 CA-C-O 126.325 2.964 . . . . 0.0 108.148 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.707 ' CE1' ' HB3' ' A' ' 110' ' ' ASN 0.322 0.0 OUTLIER -74.68 -144.19 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.314 1 CA-C-N 107.368 -4.469 . . . . 0.0 114.741 178.91 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.707 ' HB3' ' CE1' ' A' ' 109' ' ' TYR . 64.0 t30 -40.43 -17.96 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 112.956 -1.929 . . . . 0.0 109.6 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.474 ' C ' ' H ' ' A' ' 114' ' ' LYS . 3.6 tt0 -88.91 -37.35 15.35 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 117.168 -1.813 . . . . 0.0 112.952 -178.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.601 ' O ' ' NE1' ' A' ' 116' ' ' TRP 0.499 32.0 tt0 -59.6 -55.22 37.21 Favored 'General case' 0 C--N 1.282 -2.342 1 N-CA-C 93.078 -6.638 . . . . 0.0 93.078 178.904 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.679 ' HA ' ' CD1' ' A' ' 116' ' ' TRP . 1.3 m-30 -47.72 -35.33 9.56 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-N 114.846 -1.07 . . . . 0.0 111.87 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 111' ' ' GLU . 81.4 tttt -62.57 -34.39 76.87 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.641 -2.072 . . . . 0.0 107.561 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 112' ' ' GLN . 3.1 tttm -73.39 -32.54 64.51 Favored 'General case' 0 N--CA 1.419 -1.99 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.388 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TRP . . . . . 0.679 ' CD1' ' HA ' ' A' ' 113' ' ' PHE . 26.8 m95 -74.09 134.68 42.93 Favored 'General case' 0 N--CA 1.487 1.401 2 N-CA-C 123.052 4.464 . . . . 0.0 123.052 -178.797 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.411 ' HB2' ' H ' ' A' ' 118' ' ' LEU . 11.1 p-10 -108.86 -173.5 2.28 Favored 'General case' 0 C--N 1.291 -1.948 2 CA-C-N 103.69 -6.141 . . . . 0.0 121.588 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.664 ' H ' HD13 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -28.98 -114.63 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 2 CA-C-N 103.389 -6.278 . . . . 0.0 119.953 179.827 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.9 -49.41 66.81 Favored Glycine 0 N--CA 1.495 2.627 0 CA-C-N 110.515 -3.039 . . . . 0.0 108.971 -179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 146' ' ' LEU 0.325 12.0 t0 -47.27 143.68 3.2 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 111.131 -2.535 . . . . 0.0 104.819 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.957 ' O ' ' HB3' ' A' ' 146' ' ' LEU . 5.0 mt -127.55 166.96 23.36 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.967 1 N-CA-C 122.789 4.366 . . . . 0.0 122.789 -179.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.636 ' C ' ' HA ' ' A' ' 71' ' ' ALA . 1.2 mp -108.07 165.21 11.65 Favored 'General case' 0 N--CA 1.512 2.661 0 O-C-N 117.044 -3.535 . . . . 0.0 106.931 178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -145.5 108.6 0.47 Allowed Glycine 0 N--CA 1.489 2.178 2 N-CA-C 92.776 -8.13 . . . . 0.0 92.776 178.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.678 ' HB3' ' CG2' ' A' ' 70' ' ' VAL . . . -140.03 -178.29 5.39 Favored 'General case' 0 CA--C 1.439 -3.32 0 CA-C-N 124.047 3.923 . . . . 0.0 104.44 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.614 ' HB2' ' CE2' ' A' ' 40' ' ' PHE . 0.0 OUTLIER -152.43 150.03 29.22 Favored 'General case' 0 C--N 1.289 -2.055 0 O-C-N 126.709 2.506 . . . . 0.0 114.92 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 68' ' ' VAL . . . -158.72 154.69 25.77 Favored Glycine 0 N--CA 1.479 1.56 0 N-CA-C 105.76 -2.936 . . . . 0.0 105.76 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . 22.8 pttt -86.65 170.69 11.59 Favored 'General case' 0 CA--C 1.462 -2.435 1 C-N-CA 111.212 -4.195 . . . . 0.0 110.475 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.737 HD21 ' CG ' ' A' ' 53' ' ' PHE 0.257 0.1 OUTLIER -91.07 134.1 34.78 Favored 'General case' 0 C--N 1.286 -2.184 0 C-N-CA 114.216 -2.994 . . . . 0.0 106.469 -178.839 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.591 ' CD1' ' HB2' ' A' ' 139' ' ' HIS . 12.5 p90 -154.92 161.72 41.33 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 115.937 -2.305 . . . . 0.0 114.919 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -46.48 90.77 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 2 CA-C-N 106.285 -4.961 . . . . 0.0 115.193 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 137' ' ' SER . 13.8 m -94.37 -58.45 2.21 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 114.013 -1.449 . . . . 0.0 109.598 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -126.82 -45.4 1.6 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 125.77 1.918 . . . . 0.0 113.245 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 9.5 t -106.5 -25.37 11.87 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.701 -0.681 . . . . 0.0 112.542 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 130.37 2.68 4.92 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 128' ' ' LEU . 21.8 tt0 -112.5 -112.42 0.34 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 119.84 3.274 . . . . 0.0 119.84 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.592 HD12 ' C ' ' A' ' 136' ' ' LEU 0.257 0.3 OUTLIER -21.12 7.29 0.0 OUTLIER 'General case' 0 C--N 1.261 -3.278 2 N-CA-C 137.413 9.783 . . . . 0.0 137.413 -178.918 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.573 ' N ' HD12 ' A' ' 136' ' ' LEU . 18.3 t -115.98 160.49 20.18 Favored 'General case' 0 C--N 1.283 -2.304 0 C-N-CA 112.178 -3.809 . . . . 0.0 106.684 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.475 HG23 ' HA3' ' A' ' 126' ' ' GLY . 15.5 mt -96.85 145.79 8.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 117.371 -1.732 . . . . 0.0 110.33 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.591 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . 17.8 t-160 -117.03 77.95 1.17 Allowed 'General case' 0 C--N 1.289 -2.023 0 CA-C-N 111.32 -2.673 . . . . 0.0 106.809 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' CYS . . . . . . . . . . . . . 40.8 t -55.42 121.5 9.11 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 109.39 -3.55 . . . . 0.0 115.74 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.8 p -132.83 -31.66 1.3 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 110.375 -3.102 . . . . 0.0 113.844 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.14 128.81 48.99 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 106.155 -1.794 . . . . 0.0 106.155 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.465 HD23 ' CE1' ' A' ' 113' ' ' PHE . 5.6 mp -116.27 114.07 23.87 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.4 ' HB2' ' CZ ' ' A' ' 144' ' ' ARG . 0.0 OUTLIER -112.62 91.15 3.55 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-O 124.299 1.999 . . . . 0.0 110.88 -179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.629 ' HG ' ' CZ2' ' A' ' 116' ' ' TRP 0.269 4.5 mm? -77.05 161.1 28.57 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-N 111.358 -2.656 . . . . 0.0 111.204 179.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.957 ' HB3' ' O ' ' A' ' 121' ' ' ILE 0.279 1.1 pt? -78.61 -168.82 1.5 Allowed 'General case' 0 N--CA 1.425 -1.716 2 CA-C-O 133.124 6.202 . . . . 0.0 121.196 -179.492 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.529 ' N ' ' HG ' ' A' ' 146' ' ' LEU . 15.0 t -118.98 175.53 5.72 Favored 'General case' 0 C--N 1.272 -2.803 3 CA-C-N 91.266 -11.788 . . . . 0.0 102.195 178.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.53 142.35 27.44 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 110.862 -2.881 . . . . 0.0 109.248 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.346 0 CA-C-O 115.391 -2.242 . . . . 0.0 108.89 -179.985 . . . . . . . . 0 0 . 1 stop_ save_